KIMBERLY COLSTON: Open Payments
NPI 1730687138 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,813 in 163 payments from 20 companies in 2025. Trend: 2023 $2,261 · 2024 $2,559 · 2025 $2,813
Food & beverage: $2,813
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 25 | $527 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $407 |
| ABBVIE INC. | 19 | $261 |
| Alkermes, Inc. | 14 | $251 |
| Otsuka America Pharmaceutical, Inc. | 16 | $232 |
| Corium, LLC | 9 | $171 |
| Neurocrine BioSciences, Inc. | 25 | $158 |
| Noven Therapeutics, LLC | 7 | $144 |
| Tris Pharma Inc | 8 | $141 |
| Collegium Pharmaceutical, Inc. | 6 | $119 |
Products named: Auvelity, CAPLYTA, VRAYLAR, ARISTADA, REXULTI, Azstarys, INGREZZA, Xelstrym.
Industry payments across LA — which companies pay providers there.
